Medications Updated During October 2008, From Newest to Oldest

Page 1 of 2 1 2 »

ALPRAZOLAM

Alprazolam extended-release tablets are indicated for the treatment of panic disorder, with or without agoraphobia. This claim is supported on the basis of two positive studies with alprazolam extended-release tablets conducted in patients whose…

Zydus Pharmaceuticals USA Inc.28 October 2008

Pyridostigmine Bromide

Pyridostigmine bromide is indicated for pretreatment against the lethal effects of Soman nerve agent poisoning. Pyridostigmine is intended for use in conjunction with protective garments, including a mask. At the first sign of nerve agent poisoning,…

Valeant Canada Limited27 October 2008

FACTIVE (Gemifloxacin Mesylate)

FACTIVE is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (See DOSAGE AND ADMINISTRATION. and CLINICAL STUDIES.) Acute bacterial exacerbation of chronic…

Oscient Pharmaceuticals17 October 2008

CEFUROXIME AXETIL

NOTE: CEFUROXIME AXETIL TABLETS AND CEFUROXIME AXETIL FOR ORAL SUSPENSION ARE NOT BIOEQUIVALENT AND ARE NOT SUBSTITUTABLE ON A MILLIGRAM-PER-MILLIGRAM BASIS (SEE CLINICAL PHARMACOLOGY.). Cefuroxime Axetil Tablets: Cefuroxime axetil tablets are…

Ranbaxy Pharmaceuticals Inc.7 October 2008

PRAVASTATIN SODIUM

Therapy with Pravastatin Sodium Tablets should be considered in those individuals at increased risk for atherosclerosis-related clinical events as a function of cholesterol level, the presence or absence of coronary heart disease, and other risk…

Watson Laboratories, Inc.6 October 2008

Page 1 of 2 1 2 »

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.